Terms: = Bone cancer AND BCL10, CIPER, 8915, ENSG00000142867, c-E10, CARMEN, mE10, CLAP
17 results:
1. Long-Term Opioid Therapy Among Patients With Systemic Lupus Erythematosus in the Community: A Lupus Midwest Network (LUMEN) Study.
Figueroa-Parra G; Jeffery MM; Dabit JY; Chevet B; Valenzuela-Almada MO; Hocaoglu M; Osei-Onomah SA; Kurani S; Vallejo S; Achenbach SJ; Hooten WM; Barbour KE; Crowson CS; Duarte-García A
J Rheumatol; 2023 Apr; 50(4):504-511. PubMed ID: 36379579
[TBL] [Abstract] [Full Text] [Related]
2. MALT1 is a critical mediator of PAR1-driven NF-κB activation and metastasis in multiple tumor types.
McAuley JR; Bailey KM; Ekambaram P; Klei LR; Kang H; Hu D; Freeman TJ; Concel VJ; Hubel NE; Lee JL; Klei HB; Cheng J; Sekar P; Bridwell RE; Covic L; Lucas PC; McAllister-Lucas LM
Oncogene; 2019 Dec; 38(49):7384-7398. PubMed ID: 31420608
[TBL] [Abstract] [Full Text] [Related]
3. Synthesis of the 19th ArgoSpine Symposium.
Kehr P; Graftiaux A; Richard N; Mazel C
Eur J Orthop Surg Traumatol; 2015 Jul; 25 Suppl 1():S253-64. PubMed ID: 25993977
[TBL] [Abstract] [Full Text] [Related]
4. C-type lectin receptor dectin-3 mediates trehalose 6,6'-dimycolate (TDM)-induced Mincle expression through CARD9/bcl10/MALT1-dependent nuclear factor (NF)-κB activation.
Zhao XQ; Zhu LL; Chang Q; Jiang C; You Y; Luo T; Jia XM; Lin X
J Biol Chem; 2014 Oct; 289(43):30052-62. PubMed ID: 25202022
[TBL] [Abstract] [Full Text] [Related]
5. The CARD11-bcl10-MALT1 (CBM) signalosome complex: Stepping into the limelight of human primary immunodeficiency.
Turvey SE; Durandy A; Fischer A; Fung SY; Geha RS; Gewies A; Giese T; Greil J; Keller B; McKinnon ML; Neven B; Rozmus J; Ruland J; Snow AL; Stepensky P; Warnatz K
J Allergy Clin Immunol; 2014 Aug; 134(2):276-84. PubMed ID: 25087226
[TBL] [Abstract] [Full Text] [Related]
6. New indication for therapeutic potential of an old well-known drug (propranolol) for multiple myeloma.
Kozanoglu I; Yandim MK; Cincin ZB; Ozdogu H; Cakmakoglu B; Baran Y
J Cancer Res Clin Oncol; 2013 Feb; 139(2):327-35. PubMed ID: 23080133
[TBL] [Abstract] [Full Text] [Related]
7. [Orbital and ocular adnexal lymphomas. Clinico-pathological correlation in 25 cases].
Rojas Bilbao EA; Nesprias M; Pulero C; Giménez L; Zerga M; Chirife AM
Medicina (B Aires); 2010; 70(4):333-8. PubMed ID: 20679053
[TBL] [Abstract] [Full Text] [Related]
8. Oncogenic activation of NF-kappaB.
Staudt LM
Cold Spring Harb Perspect Biol; 2010 Jun; 2(6):a000109. PubMed ID: 20516126
[TBL] [Abstract] [Full Text] [Related]
9. [Abnormal bcl10 nuclear expression and chromosomal translocation in ocular adnexal mucosa-associated lymphoid tissue lymphomas].
Li BZ; Yang WT; Zhou XY; Fan YZ; Lu HF; Shi DR
Zhonghua Yan Ke Za Zhi; 2008 Jun; 44(6):545-8. PubMed ID: 19035248
[TBL] [Abstract] [Full Text] [Related]
10. Nuclear BCL-10 expression is common in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia and does not correlate with p65 NF-kappaB activation.
Merzianu M; Jiang L; Lin P; Wang X; Weber DM; Vadhan-Raj S; Nguyen MH; Medeiros LJ; Bueso-Ramos CE
Mod Pathol; 2006 Jul; 19(7):891-8. PubMed ID: 16636680
[TBL] [Abstract] [Full Text] [Related]
11. Ocular adnexal marginal zone B cell lymphoma: a clinical and pathologic study of 23 cases.
Charlotte F; Doghmi K; Cassoux N; Ye H; Du MQ; Kujas M; Lesot A; Mansour G; Lehoang P; Vignot N; Capron F; Leblond V
Virchows Arch; 2006 Apr; 448(4):506-16. PubMed ID: 16323006
[TBL] [Abstract] [Full Text] [Related]
12. bcl10 expression in ocular adnexal lymphomas.
Vejabhuti C; Harris GJ; Erickson BA; Nishino H; Chevez-Barrios P; Chang CC
Am J Ophthalmol; 2005 Nov; 140(5):836-843. PubMed ID: 16310461
[TBL] [Abstract] [Full Text] [Related]
13. t(1;14) and t(11;18) in the differential diagnosis of Waldenström's macroglobulinemia.
Ye H; Chuang SS; Dogan A; Isaacson PG; Du MQ
Mod Pathol; 2004 Sep; 17(9):1150-4. PubMed ID: 15143341
[TBL] [Abstract] [Full Text] [Related]
14. No evidence of a correlation between bcl10 expression and API2-MALT1 gene rearrangement in ocular adnexal MALT lymphoma.
Adachi A; Tamaru J; Kaneko K; Kuroda H; Miura I; Kojima T; Hoshino S; Ichinohasama R; Itoyama S
Pathol Int; 2004 Jan; 54(1):16-25. PubMed ID: 14674990
[TBL] [Abstract] [Full Text] [Related]
15. Lack of bcl10 mutations in malignant cartilaginous tumors.
Park YK; Park HR; Kim YW; Chi SG; Unni KK
Int J Mol Med; 2002 Mar; 9(3):217-9. PubMed ID: 11836626
[TBL] [Abstract] [Full Text] [Related]
16. Lack of bcl10 mutations in multiple myeloma and plasma cell leukemia.
Shih LY; Fu JF; Shurtleff SA; Morris SW; Downing JR
Genes Chromosomes Cancer; 2001 Apr; 30(4):402-6. PubMed ID: 11241793
[TBL] [Abstract] [Full Text] [Related]
17. Lack of mutations of BCL6 and bcl10 genes in mucosa-associated lymphoid tissue lymphomas of the orbital adnexa.
Chen PM; Liu JH; Yu IT; Kao SC; Lin YC; Chiang H; Fan FS; Chiou TJ; Wang WS; Yen CC
Cancer Genet Cytogenet; 2000 Nov; 123(1):44-8. PubMed ID: 11120333
[TBL] [Abstract] [Full Text] [Related]
